Regenerative Medicine Today welcomes Mr. Peter DeComo. Mr. DeComo is the Chairman and Chief Executive Officer of ALung Technologies, Inc., a company which develops respiratory assist technologies that are expected to provide a better alternative to traditional, invasive respiratory support. Mr. DeComo discusses the goal of ALung to advance lung replacement therapy as well as the challenges it faces as it nears its goals.
For more information about the ALung Technologies, Inc., please click here.
Host John Murphy.
For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter